Allergan plc Profit Margin

The latest profit margin for AGN is -15.44% as of March 2020. That compares with -45.94% in the prior-year period — up 66.4% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside Allergan plc's historical trend and sector peers before judging valuation or financial health.

Over the past year, AGN's profit margin moved from -45.94% to -15.44% — a 66.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Allergan plc's valuation or profitability profile.

Against Healthcare companies, AGN currently prints -15.44% for profit margin, while the sector average sits near 15.58%. That is roughly 199.1% below the sector mean. Large gaps often invite a closer look at Allergan plc's growth, margins, and balance sheet.

Profit Margin shows how effectively Allergan plc converts resources into returns. At -15.44%, AGN may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -45.94% in the prior-year period — up 66.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting AGN's profit margin (-15.44%), review year-over-year change from -45.94%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.